Haemonetics 4th Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website

Rhea-AI Summary

Haemonetics Corporation (NYSE: HAE) revealed its financial results for the fourth quarter of fiscal 2021, which ended on April 3, 2021. The results can be accessed on the company's Investor Relations website. Following the release, a conference call and webcast will be held on May 13, 2021, at 8:00 a.m. ET, allowing investors to engage with management and learn more about the results. The company’s offerings support healthcare improvements in blood and plasma collection, surgical services, and hospital transfusions. Detailed earnings information is also available through direct links provided in the announcement.

BOSTON, May 13, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal 2021, which ended April 3, 2021, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 13, 2021. The conference call and webcast can be accessed with the following information:

• U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
• Conference ID required for access: 8694785
• A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/xqyzme3t

In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.  

Direct link to 4Q FY21 Earnings Release:
https://haemonetics.gcs-web.com/static-files/481f6d1e-dc52-460a-9c68-776987d4e6c1 

Direct link to 4Q FY21 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/aedee021-4974-49c9-97bb-aaa441c4fc95 

A replay of the conference call and webcast will be available for one year beginning on May 13, 2021 at 11:00 a.m. ET using the conference call webcast link provided in this press release.

About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact	Media Contact
Olga Guyette, Director-Investor Relations	Carla Burigatto, VP-Communications
(781) 356-9763	(781) 348-7263
olga.guyette@haemonetics.com	carla.burigatto@haemonetics.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/haemonetics-4th-quarter-fiscal-year-2021-earnings-release-available-on-investor-relations-website-301290557.html

SOURCE Haemonetics Corporation

FAQ

What are the key details about Haemonetics' fourth quarter fiscal 2021 results?

Haemonetics Corporation announced its fourth quarter fiscal 2021 financial results on May 13, 2021. The results cover the period ending on April 3, 2021, and are available on their Investor Relations website.

When will Haemonetics hold the earnings conference call?

The earnings conference call for Haemonetics will take place on May 13, 2021, at 8:00 a.m. ET.

How can investors access Haemonetics' earnings release?

Investors can access Haemonetics' earnings release and supplemental information through their Investor Relations website, with direct links provided in the press release.

What services does Haemonetics provide?

Haemonetics offers innovative medical products and solutions focusing on blood and plasma collection, surgical services, and hospital transfusion services.